
Panlist IV 40mg Injection
Marketer
Rech Elist Pharma
Salt Composition
Pantoprazole (40mg)
Overview Panlist IV 40mg Injection
Intravenous Panlist (40mg) is a medication that lowers stomach acid production. It treats acid-related gastrointestinal disorders including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, alleviating symptoms and facilitating healing. This injection is also used for prophylaxis against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a healthcare professional only when deemed more appropriate than oral administration. Dosage is individualized based on condition and response. Treatment duration is determined by your physician; continue as prescribed even with symptom resolution. Lifestyle modifications, such as frequent, smaller meals and avoidance of caffeine, spicy foods, and fatty meals, can enhance treatment efficacy. Commonly reported side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While generally mild, persistent or bothersome side effects warrant medical attention. Prolonged use (over a year) may increase the risk of bone fractures, particularly at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. Panlist IV 40mg is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or lactating women should seek medical counsel prior to use. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Primary Ingredients of Panlist IV 40mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Panlist IV 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Panlist IV 40mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Panlist IV 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Panlist IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Panlist IV 40mg Injection works:
Acid reflux and indigestion can be eased with a single dose of Panlist IV 40mg Injection, a proton pump inhibitor (PPI) that effectively lowers stomach acid production.
SAFETY ADVICE
AlcoholUNSAFE
Combining Panlist IV 40mg Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Panlist IV 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Intravenous Panlist 40mg is likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Panlist IV 40mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Panlist IV 40mg Injection presents no need for dosage modification in individuals with renal impairment and is considered safe for their use.
LiverCAUTION
For individuals with advanced hepatic impairment, Panlist IV 40mg Injection requires careful administration. Dosage modification of Panlist IV 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Panlist IV 40mg Injection :
Omit a Panlist IV 40mg Injection dose? Seek your physician's advice.
Facts to Know About Panlist IV 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
